The Drug Enforcement Administration (DEA) held two public listening sessions on Sept. 12 and 13 to explore the possibility of creating special registration that would permit providers to prescribe medically necessary drugs by telehealth. The registration would represent a potential long-term expansion of a policy that began during the federal COVID-19 Public Health Emergency (PHE).
During the PHE, the DEA granted temporary exceptions to existing regulations, allowing the prescribing